Barclays’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,517
| Closed | -$106K | – | 4345 |
|
|
2023
Q4 | $106K | Sell |
10,517
-301,003
| -97% | -$3.03M | ﹤0.01% | 3704 |
|
|
2023
Q3 | $898K | Buy |
311,520
+301,003
| +2,862% | +$868K | ﹤0.01% | 2163 |
|
|
2023
Q2 | $40K | Sell |
10,517
-191,808
| -95% | -$730K | ﹤0.01% | 3769 |
|
|
2023
Q1 | $376K | Buy |
202,325
+116,216
| +135% | +$216K | ﹤0.01% | 2822 |
|
|
2022
Q4 | $198K | Buy |
86,109
+47,379
| +122% | +$109K | ﹤0.01% | 3103 |
|
|
2022
Q3 | $125K | Sell |
38,730
-1,700
| -4% | -$5.49K | ﹤0.01% | 3320 |
|
|
2022
Q2 | $222K | Buy |
+40,430
| New | +$222K | ﹤0.01% | 3075 |
|